Clinical improvement of adrenoleukodystrophy following intravenous gammaglobulin therapy.
A patient with adrenoleukodystrophy was successfully treated by means of intravenous gammaglobulin injections. The clinical symptoms, especially visual loss, were apparently relieved and no neurological deterioration was observed during a 18-month period following the start of the gammaglobulin treatment.
Miike
T
T
Department of Child Development, Kumamoto University Medical School, Japan.
Taku
K
K
Tamura
T
T
Ohta
J
J
Ozaki
M
M
Yamamoto
C
C
Sakai
T
T
Antoku
Y
Y
Yadomi
C
C
D000293:Adolescent; D000326:Adrenoleukodystrophy / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000276:immunology*; D002549:Diffuse Cerebral Sclerosis of Schilder / Q000276:immunology*; D004912:Erythrocytes / Q000166:cytology / Q000378:metabolism; D005227:Fatty Acids / Q000378:metabolism; D005347:Fibroblasts / Q000166:cytology / Q000378:metabolism; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D014057:Tomography, X-Ray Computed; D005719:gamma-Globulins / Q000008:administration & dosage / Q000627:therapeutic use*
D005227:Fatty Acids; D005719:gamma-Globulins